| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |